Get With The Guidelines-Heart Failure Registry

Recruiting

• Conditions: Heart Failure

• Registration Number: NCT02693509
• Lead Sponsor: American Heart Association

Brief Summary

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Detailed Description

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings.

Achievement measures tracked through Get With The Guidelines-Heart Failure:

* Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge

* Evidence-based specific beta blockers

* Measure left ventricular function

* Post-discharge appointment for heart failure patients

Quality Measures tracked through Get With The Guidelines-Heart Failure:

* Mineralocorticoid receptor antagonist at discharge

* Aldosterone antagonist at discharge

* Anticoagulation for atrial fibrillation

* Hydralazine nitrate at discharge

* DVT prophylaxis

* CRT-D or CRT-P placed or prescribed at discharge

* ICD counseling, or ICD placed or prescribed at discharge

* Influenza vaccination during flu season

* Pneumococcal vaccination

* Follow-up visit within 7 days or less

* Lab monitoring follow-up

* SGLT-2 inhibitor at discharge

* Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction

* Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients

Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm_310967.pdf

Study Timeline

• Study Start: 2005-01
• Study First Submitted: 2013-04-08
• Study First Submitted QC: 2016-02-25
• Study First Posted: 2016-02-26
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-27
• Last Update Posted: 2025-01-29
• Primary Completion: 2040-01
• Study Completion: 2040-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 128026

Inclusion Criteria

• Patients hospitalized with congestive heart failure.

Exclusion Criteria

• Patients who do not have congestive heart failure,
• Patients under age of 18,
• Patients not admitted as inpatients.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
60 day readmission rate	60 days post discharge from hospital	Percent of index encounters where there is a readmission within 60 days
90 day readmission rate	90 days post discharge from hospital	Percent of index encounters where there is a readmission within 90 days
30 day readmission rate	30 days post discharge from hospital	Percent of index encounters where there is a readmission within 30 days

Trial Locations

Locations (1)

Amy Bennett; 🇺🇸 Dallas, Texas, United States